English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Patient Daily
| Dec 3, 2025
Patients Come First spokesperson: ‘Congress must recognize the urgent need to reform the 340B Program'
Patient Daily
| Dec 3, 2025
Capricor reports positive phase III results for DMD cardiomyopathy therapy after initial FDA rejection
Patient Daily
| Dec 3, 2025
FDA proposes reducing primate use in antibody therapy testing
Patient Daily
| Dec 3, 2025
New UK/EU regulations and AI adoption shape priorities for contract research organizations
Patient Daily
| Dec 3, 2025
ENT & Allergy Associates partners with Houston group for first Texas expansion
Patient Daily
| Dec 3, 2025
American Lung Association opposes proposed weakening of federal vehicle fuel economy rules
Patient Daily
| Dec 2, 2025
American Lung Association calls for widespread flu vaccination after severe 2024–25 season
Patient Daily
| Dec 2, 2025
Experts question FDA official's claims linking child deaths to COVID-19 vaccines
Trending
+
Regulatory
B. D. Benavides
| Mar 18, 2026
Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'
+
Pharmaceuticals
Patient Daily
| Mar 22, 2026
BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+
Regulatory
Patient Daily
| Mar 20, 2026
Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+
Pharmaceuticals
Patient Daily
| Mar 17, 2026
Biogen, Sarepta, and Edgewise present new data at Muscular Dystrophy Association 2026 conference
« First
«
…
99
100
101
102
103
104
105
»
Last »